JO3276B1 - طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا. - Google Patents
طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا.Info
- Publication number
- JO3276B1 JO3276B1 JOP/2014/0157A JOP20140157A JO3276B1 JO 3276 B1 JO3276 B1 JO 3276B1 JO P20140157 A JOP20140157 A JO P20140157A JO 3276 B1 JO3276 B1 JO 3276B1
- Authority
- JO
- Jordan
- Prior art keywords
- synthesis
- ivabradine
- pharmaceutically acceptable
- acceptable acid
- methoxybycycline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1354504A FR3005658B1 (fr) | 2013-05-17 | 2013-05-17 | "procede de synthese du 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO3276B1 true JO3276B1 (ar) | 2018-09-16 |
Family
ID=48874340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2014/0157A JO3276B1 (ar) | 2013-05-17 | 2014-05-06 | طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا. |
Country Status (36)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3005658B1 (fr) * | 2013-05-17 | 2015-04-24 | Servier Lab | "procede de synthese du 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable" |
| EP3101010A1 (en) | 2015-06-03 | 2016-12-07 | Urquima S.A. | New method for the preparation of highly pure ivabradine base and salts thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2681862B1 (fr) * | 1991-09-27 | 1993-11-12 | Adir Cie | Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent. |
| FR2870537A1 (fr) * | 2004-05-19 | 2005-11-25 | Servier Lab | Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
| FR2933975B1 (fr) * | 2008-07-17 | 2011-02-18 | Servier Lab | Nouveau procede de preparation de benzocyclobutenes fonctionnalises,et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable. |
| WO2011138825A1 (ja) | 2010-05-06 | 2011-11-10 | 株式会社島津製作所 | 材料試験機 |
| HUP1000245A2 (en) * | 2010-05-07 | 2011-11-28 | Richter Gedeon Nyrt | Industrial process for the production ivabradin salts |
| FR3005658B1 (fr) * | 2013-05-17 | 2015-04-24 | Servier Lab | "procede de synthese du 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-carbonitrile, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable" |
-
2013
- 2013-05-17 FR FR1354504A patent/FR3005658B1/fr active Active
-
2014
- 2014-04-29 MY MYPI2014701053A patent/MY169174A/en unknown
- 2014-05-02 IN IN1203DE2014 patent/IN2014DE01203A/en unknown
- 2014-05-05 SG SG10201402034PA patent/SG10201402034PA/en unknown
- 2014-05-05 CN CN201410185124.1A patent/CN104163777B/zh not_active Expired - Fee Related
- 2014-05-05 AU AU2014202434A patent/AU2014202434B2/en not_active Ceased
- 2014-05-06 JO JOP/2014/0157A patent/JO3276B1/ar active
- 2014-05-08 MD MDA20140048A patent/MD4443C1/ro not_active IP Right Cessation
- 2014-05-09 NZ NZ624774A patent/NZ624774A/en not_active IP Right Cessation
- 2014-05-12 UY UY0001035561A patent/UY35561A/es not_active Application Discontinuation
- 2014-05-12 CA CA2851960A patent/CA2851960C/fr not_active Expired - Fee Related
- 2014-05-14 BR BR102014011633-8A patent/BR102014011633A2/pt not_active IP Right Cessation
- 2014-05-14 TW TW103117037A patent/TWI500596B/zh not_active IP Right Cessation
- 2014-05-14 MX MX2014005822A patent/MX345278B/es active IP Right Grant
- 2014-05-14 SA SA114350532A patent/SA114350532B1/ar unknown
- 2014-05-14 UA UAA201405094A patent/UA116337C2/uk unknown
- 2014-05-14 US US14/277,151 patent/US8859763B1/en not_active Expired - Fee Related
- 2014-05-14 GE GEAP201413468A patent/GEP20156416B/en unknown
- 2014-05-15 ZA ZA2014/03543A patent/ZA201403543B/en unknown
- 2014-05-16 SI SI201430179A patent/SI2803659T1/sl unknown
- 2014-05-16 WO PCT/FR2014/051140 patent/WO2014184501A1/fr not_active Ceased
- 2014-05-16 EA EA201400473A patent/EA026224B1/ru not_active IP Right Cessation
- 2014-05-16 LT LTEP14168559.4T patent/LT2803659T/lt unknown
- 2014-05-16 ES ES14168559.4T patent/ES2621804T3/es active Active
- 2014-05-16 RS RS20170308A patent/RS55917B1/sr unknown
- 2014-05-16 HU HUE14168559A patent/HUE031370T2/hu unknown
- 2014-05-16 ME MEP-2017-64A patent/ME02636B/me unknown
- 2014-05-16 JP JP2014101963A patent/JP5916793B2/ja active Active
- 2014-05-16 EP EP14168559.4A patent/EP2803659B1/fr active Active
- 2014-05-16 PT PT141685594T patent/PT2803659T/pt unknown
- 2014-05-16 PL PL14168559T patent/PL2803659T3/pl unknown
- 2014-05-16 KR KR1020140059053A patent/KR101625128B1/ko not_active Expired - Fee Related
- 2014-05-16 DK DK14168559.4T patent/DK2803659T3/da active
- 2014-05-16 AR ARP140101965A patent/AR096324A1/es unknown
-
2017
- 2017-03-09 HR HRP20170394TT patent/HRP20170394T1/hr unknown
- 2017-04-03 CY CY20171100398T patent/CY1120482T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX360048B (es) | Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico. | |
| MX2012001722A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
| GB2523674A (en) | Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof | |
| JO3276B1 (ar) | طريقة لتخليق 3، 4-داي ميثوكسي باي سيكلو [4. 2. 0] أوكتا-5،3،1-تراي إين-7-كربونيتريل واستخدامها لتخليق ايفابرادين والأملاح المضافة منه مع حمض مقبول صيدلانيا. | |
| UA118008C2 (uk) | Спосіб синтезу (2е)-3-(3,4-диметоксифеніл)проп-2-еннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою | |
| UA111329C2 (uk) | Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою | |
| UA117900C2 (uk) | Спосіб синтезу 3-(2-бром-4,5-диметоксифеніл)пропаннітрилу та застосування в синтезі івабрадину та його адитивних солей з фармацевтично прийнятною кислотою | |
| EA201400269A1 (ru) | Способ синтеза соединений 7,8-диметокси -1,3-дигидро-2h-3-бензазепин-2-она и применение в синтезе ивабрадина | |
| CY1117315T1 (el) | Νεα μεθοδος συνθεσης του 3-(2-βρωμο-4,5-διμεθοξυφαινυλ)προπανονιτριλιου και εφαρμογη στη συνθεση της ιβαμπραδινης και των αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ | |
| UA111156C2 (uk) | Спосіб синтезу івабрадину і його адитивних солей з фармацевтично прийнятною кислотою | |
| MX2013002990A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
| EA201400171A1 (ru) | Способ ферментативного синтеза (7s)-3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбоновой кислоты и применение в синтезе ивабрадина и его солей | |
| TH149057A (th) | กระบวนการใหม่สำหรับการสังเคราะห์ของไอวาบราดีน (ivabradine) และ เกลือของมันจากการเติมด้วยกรดที่เป็นที่ยอมรับในทางเภสัชกรรม | |
| TH148556A (th) | กระบวนการใหม่สำหรับการสังเคราะห์ของไอวาบราดีน (ivabradine) และ เกลือของมันจากการเติมด้วยกรดที่เป็นที่ยอมรับในทางเภสัชกรรม |